GEODE CAPITAL MANAGEMENT, LLC
Position in FDMT — 4D Molecular Therapeutics, Inc.
CIK 1214717
BOSTON, MA
Position in FDMT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$15,008,597
+$5,090,236 QoQ
Shares Held
1,128,466
+5.9% QoQ
Ownership
1.56%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 158 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,870,628,057 across 520 Biotechnology names. FDMT ranks #156 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in FDMT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,008,597 | 1,128,466 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $9,918,361 | 1,065,345 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,590,187 | 1,012,025 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $7,938,479 | 913,519 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $3,407,756 | 918,533 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $3,111,358 | 963,269 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $5,637,741 | 1,012,162 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $11,205,051 | 1,036,545 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $22,268,101 | 1,060,891 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $27,803,043 | 872,663 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $15,765,562 | 778,162 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $9,441,395 | 741,665 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $12,464,270 | 689,777 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $9,934,479 | 577,922 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $12,476,178 | 561,737 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,252,645 | 528,936 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,439,918 | 492,825 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $7,236,779 | 478,623 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $10,584,667 | 482,437 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $9,229,619 | 342,218 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $4,031,810 | 167,434 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $6,346,407 | 146,298 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $529,731 | 12,780 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||